ABR Radiation Oncology

ABR Radiation Oncology Primary Certification

Prostate CancerEnglish
Exam overview

Practice session

A 68-year-old with cT2N0M0 unfavorable intermediate-risk prostate adenocarcinoma (Gleason 4+3, PSA 12) is treated with definitive EBRT. Per STAMPEDE and current NCCN, what is the appropriate ADT duration?

Loading your practice session…